Table 2.

Predicted value of Corporate Health Impact Assessment

Predicted value to researchers

Evidence to inform public policy decisions

Evidence elucidating the health and health equity impacts of individual TNCs’ structures, products and practices; and how these differ between countries

Understanding of how TNC practices affecting health are influenced by international and national regulatory structures

Predicted value to civil society activists

Advocacy tool to enhance community capacity to understand and engage on issues associated with health impact of TNC operations

Facilitate community involvement in debates about TNC health impact and possible government response

Predicted value to corporations

Evidence to inform corporate policies and practices to reduce adverse and optimise positive impacts on health and health equity within their countries of operation; and to achieve greater equity of practices across countries

Predicted value to governments and policy-makers

Evidence to inform policy decisions regarding project approval and appropriate regulation